Independent consultancy specializing in growth and transformation strategies for medtech clients)
President Hired by early-stage and rapid-growth MedTech companies to secure early-stage funding and guide them through design, execution, and management of commercial/ go-to-market, operational, product portfolio, training/education, and talent strategies. Page 2
● NEURO ADVISORS, cont. Select engagements include:
● Kaneka Medical America, LLC: As a consultant, transformed the Japanese company's commercial strategy for its first U.S. entry in the neuro space (i-ED COIL™ brain aneurysm embolization coil) following 2020 FDA approval. Met with the board and senior leadership, recommending clinical registries and U.S.-based talent acquisition. Developed branding and messaging.
● EPIC Neuro, Inc.: Guided early-stage brain stimulation company from prototype to successful fundraising and clinical trials.

(North American medical solutions division of $5B globalJapanese chemical manufacturing company)
General Manager, North America, Neuro Recruited from a consultant into a C-suite role with P&Laccountability for this newly launched North American neuro business focused on the FDA-approved i-ED COIL™brain aneurysm embolization coiland expansion of the product portfolio. Oversees commercial / go-to-market strategy, business development, operations, clinical research, M&A opportunities and due diligence, finance, and HR.Reporting into the Group President.
"Lead the recruiting efforts of a 17-member sales and marketing commercial team.
● Increased annual revenues from $20k in 2021 to on track to achieve $8M in annual sales for 2023.
● Manage P&L to achieve profitability by year end 2023 through improving field sales performance, leveraging clinical research initiatives and optimizing marketing budgets.
● Plays an integral role in the identification and due diligence for the acquisition

(early-stage neurotechnology company providing solutions for complex brain surgeries; founded in 2016)
Director, U.S. Sales Recruited into a newly created position to drive the commercial launch of FDA-cleared ClearFitÒand InvisiShuntÒcranial implants. Built and managed a +100-person organization, including direst sales and 20 distributors. Owned P&Lperformance and sales strategy design and execution as well as training / education for sales team and physicians. Reported to Global Vice President of Sales & Marketing.
● More than doubled unit sales in

($13B+ global medical technology company serving orthopedics, medical/ surgical, neurotechnology, and spine markets)
Director, Medical Education & Sales Training, Neurovascular, May 2019–January 2020 In the midst of restructuring, selected to re-energize the Medical Education and Sales Training teams.
● Built 15-member team serving KOLs / physicians and 85 Sales Representatives. U.S. team achieve double-digit YoY growth.
● Team delivered hundreds of product training, physician peer-to-peer, and pathway education programs.

Hand-picked to expand organization to include both New Technology Team (flow diverter) and Stroke Therapy Awareness Team (STAT) capabilities. Managed NTT Group Manager, 4 NTT Managers, 2 STAT Group Managers, and 10 STATManagers.
● Defined strategy and led execution. Within first quarter of launch, on track to deliver $16M annual sales against $8M goal.
● Extensive training and international case observation resulted in the flawless execution of the first 100 cases.
● STAT team trained ~18K+ providers annually. Reorganized team to focus on prehospital stroke care pathway.

Led high-profile downstream marketing team to leverage Concentric Medical acquisition in driving entry into the stroke care market.
● Created a 15-member Stroke Therapy Awareness Team (STAT) that drove all U.S. downstream marketing across the product life cycle, education, market development, integration of voice of customer into R&D, and investigator-initiated clinical trials.
● Team enabled 1K+ customer touches in 2013 and trained ~10K+ healthcare providers annually in 2015 and 2016.

($7B+ global medical technology company serving radiology, cardiology, neurology, endoscopy, oncology, urology, and gynecology markets)
Regional Sales Manager, Southeast Region, Neurovascular, June 2007–December 2012 (managed until March 2013)
● Grew region 50% (to $25M revenue). Region of the Year (2009–2011). Winner of Stryker Legacy Award (Platinum, 2010).
● Key role in the post-merger integration of Boston Scientific into Stryker.